NCT06776133 Evaluation of the Correlation Between Vein Size Inferior Cava and Right Atrial Pressure in Pediatric Age and Creation of a Possible Predictive Model
| NCT ID | NCT06776133 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Congenital Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,100 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,100 participants in total. It began in 2022-08-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to demonstrate the presence of a correlation between echographic measurements of the inferior vena cava (IVC) normalized for the pediatric population and right atrial pressures (RAP) measured by central venous catheter (CVC) so as to create a predictive model of the value of right atrial pressures using echocardiographic parameters in the pediatric population. This study is single-center longitudinal and involves retrospective and prospective data collection.
Eligibility Criteria
Inclusion Criteria: * Pediatric patients aged 0-18 years undergoing central venous catheter (CVC) placement in the course of the diagnosis performed at our center * Obtaining informed consent from parent/guardian in case of minors Exclusion Criteria: \- Patients with univentricular cardiac physiology, nonsinus heart rhythm, mechanical ventilation, Inferior vena cava thrombosis and patients with isomerism
Contact & Investigator
Simone Bonetti, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06776133 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Congenital Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06776133 currently recruiting?
Yes, NCT06776133 is actively recruiting participants. Contact the research team at simone.bonetti@aosp.bo.it for enrollment information.
Where is the NCT06776133 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06776133 clinical trial?
NCT06776133 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Simone Bonetti, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 1,100 participants.